TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T44068	Adrenergic receptor beta-1	B0F7HP	(+/-)-N-[5-(2-Bromo-1-hydroxyethyl)isoxazol-3-yl]methanesulfonamide	Investigative	44423639	C10H19N3O4S	277.34	CC(C)(C)NCC(C1=CC(=NO1)NS(=O)(=O)C)O	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B1B3IC	N-[4-[2-[[(2S)-2-Hydroxy-3-[4-(methanesulfonamido)phenoxy]propyl]amino]ethyl]phenyl]-2-pyridin-2-ylacetamide	Investigative	44574685	C25H30N4O5S	498.6	CS(=O)(=O)NC1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CC=CC=N3)O	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B1JE0V	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(3-nitrophenyl)thiourea;hydrochloride	Investigative	49861307	C24H27ClN4O4S	503	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC(=CC=C3)[N+](=O)[O-])O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B1YC8S	1-(2-Chlorophenyl)-3-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]thiourea;hydrochloride	Investigative	73352659	C24H27Cl2N3O2S	492.5	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=CC=C3Cl)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B20YJD	Chembl4246134	Investigative	145984792	C27H31N3O4	461.6	CC(=O)NCC1=CC(=CC=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=O)C3=CC=CC=C3)O	EC50 = 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B23XSU	Chembl4159562	Investigative	145960116	C21H30ClN3O5S	472	CCCNCC(COC1=CC=C(C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B31CSQ	(4-{(R)-2-[(R)-2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-propyl}-phenoxymethyl)-methyl-phosphinic acid	Investigative	44286980	C19H25ClNO4P	397.8	C[C@H](CC1=CC=C(C=C1)OCP(=O)(C)O)NC[C@@H](C2=CC(=CC=C2)Cl)O	Ki = 140000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B47VLT	Disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate	Investigative	5312115	C20H18ClNNa2O7	465.8	C[C@H](CC1=CC2=C(C=C1)OC(O2)(C(=O)[O-])C(=O)[O-])NC[C@@H](C3=CC(=CC=C3)Cl)O.[Na+].[Na+]	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B54BKT	1-(4-(Piperazin-1-yl)phenyl)ethanone	Investigative	97269	C12H16N2O	204.27	CC(=O)C1=CC=C(C=C1)N2CCNCC2	IC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B57BPY	1-Cyclohexyl-3-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]thiourea;hydrochloride	Investigative	49861306	C24H34ClN3O2S	464.1	C1CCC(CC1)NC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B5Q8IK	Methyl 4-[[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]carbamothioylamino]benzoate;hydrochloride	Investigative	49861315	C26H30ClN3O4S	516.1	COC(=O)C1=CC=C(C=C1)NC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B67YHI	6-Chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)quinoline	Investigative	24894134	C22H17Cl2FN4O	443.3	C1CN(CCC1C2=NC(=NO2)C3=C(C=C(C=C3)F)Cl)C4=CN=C5C=CC(=CC5=C4)Cl	EC50 ~ 50000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B6MB3R	4-(5-Butyl-[1,2,4]oxadiazol-3-yl)-N-{4-[2-((R)-2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-benzenesulfonamide	Investigative	44280860	C27H31N5O4S	521.6	CCCCC1=NC(=NO1)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	IC50 = 55000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B6S1JU	N-{5-[2-(4-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenylsulfamoyl}-phenyl)-thiazol-4-yl]-pentyl}-acetamide	Investigative	44301886	C31H37N5O4S2	607.8	CC(=O)NCCCCCC1=CSC(=N1)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	IC50 = 50000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B6VCO2	N-[6-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin-1-ylmethoxy)-naphthalen-2-yl]-4-(3-hexyl-ureido)-benzenesulfonamide	Investigative	9896742	C33H38N4O6S	618.7	CCCCCCNC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC3=C(C=C2)C=C(C=C3)OCC4C5=CC(=C(C=C5CCN4)O)O	IC50 = 80000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B6YZ3S	(4-{(R)-2-[(R)-2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-propyl}-phenoxymethyl)-phosphonic acid	Investigative	44286964	C18H23ClNO5P	399.8	C[C@H](CC1=CC=C(C=C1)OCP(=O)(O)O)NC[C@@H](C2=CC(=CC=C2)Cl)O	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B71NQZ	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-phenylurea;hydrochloride	Investigative	52949022	C24H28ClN3O3	441.9	C1=CC=C(C=C1)NC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B7F4PW	N-[4-[2-[[(2R)-2-Hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]quinoline-3-sulfonamide	Investigative	44335833	C24H24N4O3S	448.5	C1=CC=C2C(=C1)C=C(C=N2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	IC50 = 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B7I8XR	1-(4-Chlorophenyl)-3-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]thiourea;hydrochloride	Investigative	73357212	C24H27Cl2N3O2S	492.5	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=C(C=C3)Cl)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B7K8OE	N-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-2-pyridin-2-ylacetamide	Investigative	44574686	C24H27N3O3	405.5	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CC=CC=N3)O	EC50 = 120000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B7O8KB	4-(4-Benzofuran-2-yl-thiazol-2-yl)-N-{4-[2-(2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-benzenesulfonamide	Investigative	44301880	C32H28N4O4S2	596.7	C1=CC=C2C(=C1)C=C(O2)C3=CSC(=N3)C4=CC=C(C=C4)S(=O)(=O)NC5=CC=C(C=C5)CCNC[C@@H](C6=CN=CC=C6)O	IC50 = 90000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B7QV6A	N-[4-(Methylsulfonylamino)phenyl]-4-phenylpiperazine-2-carboxamide	Investigative	15123377	C18H22N4O3S	374.5	CS(=O)(=O)NC1=CC=C(C=C1)NC(=O)C2CN(CCN2)C3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B8EPO9	Chembl4173735	Investigative	145951865	C15H26ClN3O4S	379.9	CNCC(COC1=CC=C(C=C1)S(=O)(=O)N2CCN(CC2)C)O.Cl	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B8PC9R	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(2-nitrophenyl)thiourea;hydrochloride	Investigative	49861311	C24H27ClN4O4S	503	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=CC=C3[N+](=O)[O-])O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B9K3NX	N-[3'-(6,7-Dihydroxy-1,2,3,4-tetrahydroisoquinoline-1-ylmethyl)-4-biphenylyl]-4-(3-hexylureido)benzenesulfonamide	Investigative	9962058	C35H40N4O5S	628.8	CCCCCCNC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)C3=CC=CC(=C3)CC4C5=CC(=C(C=C5CCN4)O)O	IC50 = 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	B9PSC5	1-(4-Fluorophenyl)-3-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]thiourea;hydrochloride	Investigative	49861317	C24H27ClFN3O2S	476	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=C(C=C3)F)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BA0FL8	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(4-iodophenyl)thiourea;hydrochloride	Investigative	49861318	C24H27ClIN3O2S	583.9	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=C(C=C3)I)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BB8V0U	1-(3-Chlorophenyl)-3-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]thiourea;hydrochloride	Investigative	73349644	C24H27Cl2N3O2S	492.5	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC(=CC=C3)Cl)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BC8I2Y	4-[(S)-2-Hydroxy-3-[1-(3,4-dimethoxyphenylsulfonyl)-4-piperidinylamino]propoxy]-9H-carbazole	Investigative	9915235	C28H33N3O6S	539.6	COC1=C(C=C(C=C1)S(=O)(=O)N2CCC(CC2)NC[C@@H](COC3=CC=CC4=C3C5=CC=CC=C5N4)O)OC	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BC9Q3S	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-phenylthiourea;hydrochloride	Investigative	49861310	C24H28ClN3O2S	458	C1=CC=C(C=C1)NC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BDBE53	N-Methyl-5-(phenylsulfamoyl)-2,3-dihydro-1H-indole-1-carboxamide	Investigative	44298761	C16H17N3O3S	331.4	CNC(=O)N1CCC2=C1C=CC(=C2)S(=O)(=O)NC3=CC=CC=C3	IC50 = 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BE0WR5	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(4-nitrophenyl)thiourea;hydrochloride	Investigative	44517691	C24H27ClN4O4S	503	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=C(C=C3)[N+](=O)[O-])O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BEOH27	3-(Butyl-4-{4-[((2R)-2-hydroxy-2-{4-hydroxy-3-[(methylsulfonyl)amino]phenyl}-ethyl)amino]-1-piperidineyl}anilino)-3-oxopropanoic acid	Investigative	10076548	C27H38N4O7S	562.7	CCCCN(C1=CC=C(C=C1)N2CCC(CC2)NC[C@@H](C3=CC(=C(C=C3)O)NS(=O)(=O)C)O)C(=O)CC(=O)O	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BF3D0G	4-[4-(4-Hexyl-phenyl)-thiazol-2-yl]-N-{4-[2-((R)-2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-benzenesulfonamide	Investigative	44301617	C36H40N4O3S2	640.9	CCCCCCC1=CC=C(C=C1)C2=CSC(=N2)C3=CC=C(C=C3)S(=O)(=O)NC4=CC=C(C=C4)CCNC[C@@H](C5=CN=CC=C5)O	IC50 = 52000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BFH91G	3-(2-{(R)-2-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-propyl}-thiazol-5-yl)-propionic acid	Investigative	15221055	C17H21ClN2O3S	368.9	C[C@H](CC1=NC=C(S1)CCC(=O)O)NCC(C2=CC(=CC=C2)Cl)O	Ki = 58100 nM	Poor binder
T44068	Adrenergic receptor beta-1	BFK7I3	4-[5-(3-Hydroxy-pentyl)-[1,2,4]oxadiazol-3-yl]-N-{4-[2-((R)-2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-benzenesulfonamide	Investigative	44281073	C28H33N5O5S	551.7	CCC(CCC1=NC(=NO1)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O)O	IC50 = 56000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BFZ29M	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(2-phenylethyl)thiourea;hydrochloride	Investigative	49861305	C26H32ClN3O2S	486.1	C1=CC=C(C=C1)CCNC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BG35KW	4-{(S)-3-[1-(3,4-Dimethoxy-benzenesulfonyl)-piperidin-4-ylamino]-2-hydroxy-propoxy}-1,3-dihydro-benzoimidazol-2-one	Investigative	10278987	C23H30N4O7S	506.6	COC1=C(C=C(C=C1)S(=O)(=O)N2CCC(CC2)NC[C@@H](COC3=CC=CC4=C3NC(=O)N4)O)OC	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BH1E7K	Chembl4174295	Investigative	145949554	C22H32ClN3O5S	486	CC(C)(C)NCC(COC1=CC=C(C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BH3YL0	[1-[4-[2-[[2-Hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl]amino]ethyl]phenyl]piperidin-4-yl]-phenylmethanone	Investigative	90644148	C29H34N2O4	474.6	C1CN(CCC1C(=O)C2=CC=CC=C2)C3=CC=C(C=C3)CCNCC(C4=CC(=C(C=C4)O)CO)O	Ki = 125892.54 nM	Poor binder
T44068	Adrenergic receptor beta-1	BHG19T	N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[5-(4-oxo-pentyl)-[1,2,4]oxadiazol-3-yl]-benzenesulfonamide	Investigative	12043159	C28H31N5O5S	549.6	CC(=O)CCCC1=NC(=NO1)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	IC50 = 70000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BI51PN	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(4-sulfamoylphenyl)thiourea;hydrochloride	Investigative	49861308	C24H29ClN4O4S2	537.1	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=C(C=C3)S(=O)(=O)N)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BJ2P6G	Phenyl N-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]carbamate;hydrochloride	Investigative	49861309	C24H27ClN2O4	442.9	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=O)OC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BJBM81	beta3-AR agonist 2	Investigative	10008017	C27H38N4O7S	562.7	CC(C)C[C@@H](C(=O)O)NC(=O)C1=CC=C(C=C1)N2CCC(CC2)NC[C@@H](C3=CC(=C(C=C3)O)NS(=O)(=O)C)O	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BJZI84	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-pyrimidin-2-ylacetamide	Investigative	44127169	C23H26N4O4	422.5	C1=CN=C(N=C1)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=C(C=C3)O)O	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BK04XN	4-{5-[(4-Fluoro-phenyl)-hydroxy-methyl]-[1,2,4]oxadiazol-3-yl}-N-{4-[2-((R)-2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-benzenesulfonamide	Investigative	44281470	C30H28FN5O5S	589.6	C1=CC(=CN=C1)[C@H](CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=C(C=C3)C4=NOC(=N4)C(C5=CC=C(C=C5)F)O)O	IC50 = 65000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BK5JI7	N-[4-[[4-[2-[[(2R)-2-Hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]sulfamoyl]phenyl]pentanamide	Investigative	44335588	C26H32N4O4S	496.6	CCCCC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)CCNC[C@@H](C3=CN=CC=C3)O	IC50 = 60000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BK7J1N	N-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]benzamide;hydrochloride	Investigative	49861313	C24H27ClN2O3	426.9	C1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BK81UH	N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[3-(4-methoxy-butyl)-2-oxo-imidazolidin-1-yl]-benzenesulfonamide	Investigative	44377665	C29H37N5O5S	567.7	COCCCCN1CCN(C1=O)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	IC50 = 50000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BK8EH2	Chembl4166379	Investigative	145956144	C25H30ClN3O5S	520	C1=CC=C(C=C1)CNCC(COC2=CC=C(C=C2)C(=O)NCCC3=CC=C(C=C3)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BL4H3S	4-(4-Benzo[b]thiophen-2-yl-thiazol-2-yl)-N-{4-[2-((R)-2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-benzenesulfonamide	Investigative	44301881	C32H28N4O3S3	612.8	C1=CC=C2C(=C1)C=C(S2)C3=CSC(=N3)C4=CC=C(C=C4)S(=O)(=O)NC5=CC=C(C=C5)CCNC[C@@H](C6=CN=CC=C6)O	IC50 = 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BLBJ01	Chembl4160295	Investigative	145958632	C10H17ClN2O4S	296.77	CNCC(COC1=CC=C(C=C1)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BM37YZ	N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[2-oxo-3-(4,4,4-trifluoro-butyl)-2,3-dihydro-imidazol-1-yl]-benzenesulfonamide	Investigative	44377755	C28H30F3N5O4S	589.6	C1=CC(=CN=C1)[C@H](CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=C(C=C3)N4C=CN(C4=O)CCCC(F)(F)F)O	IC50 = 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BNAJ59	N-[4-[2-[[(2R)-2-Hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-2-phenylethanesulfonamide	Investigative	44335882	C23H27N3O3S	425.5	C1=CC=C(C=C1)CCS(=O)(=O)NC2=CC=C(C=C2)CCNC[C@@H](C3=CN=CC=C3)O	IC50 = 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BNSY10	Chembl4175397	Investigative	145950880	C22H30ClN3O6S	500	C1COCCN1CC(COC2=CC=C(C=C2)C(=O)NCCC3=CC=C(C=C3)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BO42ED	(4-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenylsulfamoyl}-phenyl)-carbamic acid propyl ester	Investigative	44335628	C25H30N4O5S	498.6	CCCOC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)CCNC[C@@H](C3=CN=CC=C3)O	IC50 = 60000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BRD78O	Acetic acid;3-[6-[4-[[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl]amino]butoxy]hexyl]benzenesulfonamide	Investigative	42625742	C27H42N2O8S	554.7	CC(=O)O.C1=CC(=CC(=C1)S(=O)(=O)N)CCCCCCOCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O	EC50 = 79432.82 nM	Poor binder
T44068	Adrenergic receptor beta-1	BS4N5F	4-[(S)-2-Hydroxy-3-[1-(4-methoxyphenylsulfonyl)-4-piperidinylamino]propoxy]-9H-carbazole	Investigative	10301101	C27H31N3O5S	509.6	COC1=CC=C(C=C1)S(=O)(=O)N2CCC(CC2)NC[C@@H](COC3=CC=CC4=C3C5=CC=CC=C5N4)O	EC50 = 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BSJ17G	4-[2-[2-[4-(4-Benzylpiperidin-1-yl)phenyl]ethylamino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol	Investigative	90644146	C29H36N2O3	460.6	C1CN(CCC1CC2=CC=CC=C2)C3=CC=C(C=C3)CCNCC(C4=CC(=C(C=C4)O)CO)O	Ki = 79432.82 nM	Poor binder
T44068	Adrenergic receptor beta-1	BSWB94	(2S)-1-[2-(4-Anilinophenyl)ethylamino]-3-phenoxypropan-2-ol;hydrochloride	Investigative	49861321	C23H27ClN2O2	398.9	C1=CC=C(C=C1)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BTUJ56	Chembl4167532	Investigative	145955012	C20H28ClN3O6S	474	C1=CC(=CC=C1CCNC(=O)C2=CC=C(C=C2)OCC(CNCCO)O)S(=O)(=O)N.Cl	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BTZ56V	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(4-methoxyphenyl)thiourea;hydrochloride	Investigative	44517695	C25H30ClN3O3S	488	COC1=CC=C(C=C1)NC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BU31SB	Chembl4174691	Investigative	145952345	C19H26ClN3O5S	443.9	CNCC(COC1=CC=C(C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BU42KJ	N-[4-[2-[[(2R)-2-Hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]propane-2-sulfonamide	Investigative	44335844	C18H25N3O3S	363.5	CC(C)S(=O)(=O)NC1=CC=C(C=C1)CCNC[C@@H](C2=CN=CC=C2)O	IC50 = 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BU63KD	N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[2-oxo-3-(3-oxo-3-pyrrolidin-1-yl-propyl)-imidazolidin-1-yl]-benzenesulfonamide	Investigative	44461488	C31H38N6O5S	606.7	C1CCN(C1)C(=O)CCN2CCN(C2=O)C3=CC=C(C=C3)S(=O)(=O)NC4=CC=C(C=C4)CCNC[C@@H](C5=CN=CC=C5)O	IC50 = 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BUHN63	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(4-methylphenyl)thiourea;hydrochloride	Investigative	49861316	C25H30ClN3O2S	472	CC1=CC=C(C=C1)NC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BVZQ62	1-(4-Bromophenyl)-3-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]thiourea;hydrochloride	Investigative	49861314	C24H27BrClN3O2S	536.9	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=C(C=C3)Br)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BW19NX	Chembl4162920	Investigative	145958250	C22H32ClN3O5S	486	CCC(C)NCC(COC1=CC=C(C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BW1BA7	(4-{(R)-2-[(R)-2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-propyl}-phenoxymethyl)-phosphonic acid monoisopropyl ester	Investigative	44287268	C21H29ClNO5P	441.9	C[C@H](CC1=CC=C(C=C1)OCP(=O)(O)OC(C)C)NC[C@@H](C2=CC(=CC=C2)Cl)O	Ki = 139000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BW3D9A	2-(4-{4-[2-Hydroxy-2-(4-hydroxy-3-methanesulfonylamino-phenyl)-ethylamino]-piperidin-1-yl}-benzoylamino)-3-methyl-butyric acid	Investigative	10602703	C26H36N4O7S	548.7	CC(C)[C@@H](C(=O)O)NC(=O)C1=CC=C(C=C1)N2CCC(CC2)NC[C@@H](C3=CC(=C(C=C3)O)NS(=O)(=O)C)O	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BW5CT2	Chembl4170536	Investigative	145956073	C17H23ClN2O4S	386.9	CNCC(COC1=CC=C(C=C1)S(=O)(=O)NCC2=CC=CC=C2)O.Cl	Ki = 79432.82 nM	Poor binder
T44068	Adrenergic receptor beta-1	BWAS13	N-[4-[4-[[(R)-2-Hydroxy-2-[4-hydroxy-3-[(methylsulfonyl)amino]phenyl]ethyl]amino]piperidine-1-yl]benzoyl]-L-phenylalanine	Investigative	10651147	C30H36N4O7S	596.7	CS(=O)(=O)NC1=C(C=CC(=C1)[C@H](CNC2CCN(CC2)C3=CC=C(C=C3)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)O)O)O	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BWM03V	Chembl4167473	Investigative	145956164	C20H28ClN3O5S	458	CCNCC(COC1=CC=C(C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BWO9S2	1-Benzyl-3-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]thiourea;hydrochloride	Investigative	49861323	C25H30ClN3O2S	472	C1=CC=C(C=C1)CNC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BX14NK	4-{(S)-2-Hydroxy-3-[1-(4-methoxy-benzenesulfonyl)-piperidin-4-ylamino]-propoxy}-1,3-dihydro-benzoimidazol-2-one	Investigative	10140428	C22H28N4O6S	476.5	COC1=CC=C(C=C1)S(=O)(=O)N2CCC(CC2)NC[C@@H](COC3=CC=CC4=C3NC(=O)N4)O	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BXM94T	[(4-{4-[((2R)-2-Hydroxy-2-[4-hydroxy-3-[(methylsulfonyl)amino]phenyl]ethyl)amino]-1-piperidinyl}benzoyl)amino]acetic acid	Investigative	10553602	C23H30N4O7S	506.6	CS(=O)(=O)NC1=C(C=CC(=C1)[C@H](CNC2CCN(CC2)C3=CC=C(C=C3)C(=O)NCC(=O)O)O)O	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BY7HF8	Chembl4170908	Investigative	145950894	C24H36ClN3O5S	514.1	CC(C)N(CC(COC1=CC=C(C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)O)C(C)C.Cl	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BYG12C	(S)-N-(4-(2-(2-Hydroxy-3-phenoxypropylamino)ethyl)phenyl)benzenesulfonamide	Investigative	45269853	C23H26N2O4S	426.5	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=CC=C3)O	EC50 = 78000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BYJZ36	Chembl4170860	Investigative	145949377	C21H30ClN3O5S	472	CC(C)NCC(COC1=CC=C(C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BYV61Z	2-(Hydroxymethyl)-4-[1-hydroxy-2-[2-[4-[4-(3-phenylpropyl)piperidin-1-yl]phenyl]ethylamino]ethyl]phenol	Investigative	90644147	C31H40N2O3	488.7	C1CN(CCC1CCCC2=CC=CC=C2)C3=CC=C(C=C3)CCNCC(C4=CC(=C(C=C4)O)CO)O	Ki = 125892.54 nM	Poor binder
T44068	Adrenergic receptor beta-1	BZL05F	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(3-methoxyphenyl)thiourea;hydrochloride	Investigative	44517693	C25H30ClN3O3S	488	COC1=CC=CC(=C1)NC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T44068	Adrenergic receptor beta-1	BZY43W	(S)-1-[1-(4-Butoxy-benzenesulfonyl)-piperidin-4-ylamino]-3-(9H-carbazol-4-yloxy)-propan-2-ol	Investigative	10144004	C30H37N3O5S	551.7	CCCCOC1=CC=C(C=C1)S(=O)(=O)N2CCC(CC2)NC[C@@H](COC3=CC=CC4=C3C5=CC=CC=C5N4)O	EC50 ~ 100000 nM	Poor binder